Signatera is a personalized tumor informed assay that allows serially monitoring of ctDNA levels in a quantiative manner. The test is used to detect molecular residual disease, surveillance for early recurrence monitoring, and treatment response monitoring.
Facebook
X
LinkedIn
Forward